Last $2.53 USD
Change Today +0.01 / 0.40%
Volume 32.9K
VRML On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - vermillion inc (VRML)

Name (Connections)Board RelationshipsTitleKey Developments
Peter Roddy 11 RelationshipsDirector and Chairman of Audit CommitteeCiphergen Biosystems Inc. Announces Restatement of Financial Results for the Second Quarter of 2005; Reports Earnings Results for the Third Quarter and Nine Months of 2005 ; Announces Management Changes
12/21/05
Eric Varma M.D. 11 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit CommitteeCiphergen Biosystems Inc. to Restate Earnings Results for the Second Quarter of 2005
11/16/05
James Burns 86 RelationshipsDirector, Member of Audit Committee and Member of Compensation CommitteeVermillion, Inc. announced delayed 10-Q filing
05/17/10

Compensation Committee* - vermillion inc (VRML)

Name (Connections)Board RelationshipsTitle
James Burns 86 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Eric Varma M.D. 11 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
VRML Compensation vs. Industry
184.0K
376.2K
Chief Financial Officer
Share price activity for VERMILLION INC (VRML)
52 Week Price Performance
VRML
Industry Average

Nominating Committee* - vermillion inc (VRML)

Name (Connections)Board RelationshipsTitleKey Developments
Carl Severinghaus 11 RelationshipsDirector and Chairman of Nominating & Corporate Governance CommitteeVermillion, Inc. Appoints Judith K. Wolf as Chief Medical Officer, Effective September 15, 2014
06/17/14
Robert Goggin III 11 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeVermillion, Inc. Announces Executive Changes
04/23/14

Corporate Governance Committee* - vermillion inc (VRML)

Name (Connections)Board RelationshipsTitle
Robert Goggin III 11 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Carl Severinghaus 11 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
VRML and Competitor
Insiders vs. External
Board
17%
83%
Vermillion, Inc.
9%
91%
Imperial Innovations Group plc
10%
90%
Health Discovery Corporation
14%
86%
Miraculins Inc.
100%
0%
Arrayit Corporation
17%
83%
MDxHealth SA
Insiders
External Board Members

Advisory Committee* - vermillion inc (VRML)

Name (Board Relationships)/Title Board Affiliations
Robert Bast 11 Relationships
Member of Scientific Advisory Board
No other board affiliations
Walter Carney 21 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Chan 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
John Cooke 61 Relationships
Member of Scientific Advisory Board
No other board affiliations
Donald Munroe 11 Relationships
Chief Scientific Officer, Senior Vice President of Business Development and Member of Scientific Advisory Board
No other board affiliations
Gordon Whiteley 11 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $2.53 USD +0.01

VRML Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arrayit Corp $0.15 USD 0.00
Health Discovery Corp $0.02 USD 0.00
Imperial Innovations Group PLC 450.00 GBp -1.50
MDxHealth €3.42 EUR +0.072
Miraculins Inc C$0.17 CAD +0.005
View Industry Companies
 

Industry Analysis

VRML

Industry Average

Valuation VRML Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 35.6x
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 25.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.